A well-characterized example is SRSF2, a splicing factor with a stimulatory effect on NMD [112,113], which is commonly mutated in Pro95 in patients affected by acute myeloid leukemia (AML) [111,114,115,116]. Here, SLU7 is linked to acute myeloid leukemia.